COSMEGEN

This brand name is authorized in Canada, Estonia, France, Japan, Malta, New Zealand, Romania, United Kingdom, United States

Active ingredients

The drug COSMEGEN contains one active pharmaceutical ingredient (API):

1 Dactinomycin UNII 1CC1JFE158 - DACTINOMYCIN

Dactinomycin is an antineoplastic antibiotic derived from Streptomyces parvullus. Stable complexes are formed with DNA through intercalation and DNA-dependent RNA synthesis is selectively inhibited. Protein and DNA synthesis are inhibited to a lesser extent. Read about Dactinomycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
COSMEGEN Lyophilised powder for solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01DA01	Dactinomycin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DA Actinomycines
Discover more medicines within L01DA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00213071
Country: EE	Ravimiamet	Identifier(s): 1611188
Country: FR	Base de données publique des médicaments	Identifier(s): 66507634
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 44967
Country: JP	医薬品医療機器総合機構	Identifier(s): 4233400D1036
Country: MT	Medicines Authority	Identifier(s): AA135/00202
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 488
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69339001
Country: US	FDA, National Drug Code	Identifier(s): 55292-811